Search Results - "Howles, CM"

Refine Results
  1. 1
  2. 2

    Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study by Olivennes, F, Howles, CM, Borini, A, Germond, M, Trew, G, Wikland, M, Zegers-Hochschild, F, Saunders, H, Alam, V

    Published in Reproductive biomedicine online (2009)
    “…Abstract The CONSORT dosing algorithm individualizes recombinant human FSH (r-hFSH) doses for assisted reproduction technologies, assigning 37.5 IU increments…”
    Get full text
    Journal Article
  3. 3

    Recombinant gonadotrophins in reproductive medicine: the gold standard of today by Howles, CM

    Published in Reproductive biomedicine online (01-02-2011)
    “…Abstract Since the early 1980s when gonadotrophins were first routinely used in ovarian stimulation regimens, there have been important advances in…”
    Get full text
    Journal Article
  4. 4

    Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements by Homburg, R, Howles, C M

    Published in Human reproduction update (01-09-1999)
    “…Low-dose follicle stimulating hormone (FSH) regimens for induction of ovulation for women with polycystic ovaries have succeeded in reducing the rate of…”
    Get full text
    Journal Article
  5. 5

    Role of LH and FSH in ovarian function by Howles, Colin M

    Published in Molecular and cellular endocrinology (30-03-2000)
    “…Human gonadotrophin preparations have been used in the treatment of infertility for almost four decades. The earliest preparations were derived from urine from…”
    Get full text
    Journal Article
  6. 6

    Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques by Bergh, C, Howles, C M, Borg, K, Hamberger, L, Josefsson, B, Nilsson, L, Wikland, M

    Published in Human reproduction (Oxford) (01-10-1997)
    “…A prospective, randomized, comparative, assessor-blind study was carried out in two centres to compare the efficacy and safety of recombinant human follicle…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Recombinant gonadotrophins in reproductive medicine: the gold standard of today by Howles, CM

    Published in Reproductive biomedicine online (2006)
    “…Since the early 1980s when gonadotrophins were first routinely used in ovarian stimulation regimens, there have been important advances in pharmaceutical…”
    Get full text
    Journal Article
  9. 9

    Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome by Loumaye, E, Engrand, P, Howles, C M, O'Dea, L

    Published in Fertility and sterility (01-05-1997)
    “…To analyze the role of serum LH and of E2 secretion on IVF-ET outcome in patients stimulated with FSH. Using data from three studies, we analyzed ovarian…”
    Get more information
    Journal Article
  10. 10

    Progesterone supplementation during cryopreserved embryo transfer cycles: efficacy and convenience of two vaginal formulations by Lan, VTN, Tuan, PH, Canh, LT, Tuong, HM, Howles, CM

    Published in Reproductive biomedicine online (2008)
    “…Abstract Sequential exogenous oestradiol and progesterone are often used to prepare the endometrium in frozen embryo transfer (FET) cycles. This open-label,…”
    Get full text
    Journal Article
  11. 11

    A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI by Wikland, M., Bergh, C., Borg, K., Hillensjö, T., Howles, C.M., Knutsson, A., Nilsson, L., Wood, M.

    Published in Human reproduction (Oxford) (01-08-2001)
    “…BACKGROUND: A prospective randomized study was carried out in two centres to compare the number of oocytes retrieved after two different starting doses of…”
    Get full text
    Journal Article
  12. 12

    Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK by Daya, S., Ledger, W., Auray, J.P., Duru, G., Silverberg, K., Wikland, M., Bouzayen, R., Howles, C.M., Beresniak, A.

    Published in Human reproduction (Oxford) (01-12-2001)
    “…BACKGROUND: The purpose of this study was to undertake an economic evaluation to compare the cost-effectiveness of recombinant (r)FSH with urinary (u)FSH for…”
    Get full text
    Journal Article
  13. 13

    Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? by Howles, C.M., Loumaye, E., Germond, M., Yates, R., Brinsden, P., Healy, D., Bonaventura, L.M., Strowitzki, T.

    Published in Human reproduction (Oxford) (01-08-1999)
    “…Treatment with growth hormone-releasing factor (GRF) has been reported to improve the ovarian response to gonadotrophins in women who respond poorly to ovarian…”
    Get full text
    Journal Article
  14. 14

    No influence of body weight on pregnancy rate in patients treated with cetrorelix according to the single- and multiple-dose protocols by Engel, JB, Ludwig, M, Junge, K, Howles, CM, Diedrich, K

    Published in Reproductive biomedicine online (2003)
    “…The question of whether adjustment to body weight is necessary in in-vitro fertilization (IVF) cycles using GnRH antagonists is currently under discussion…”
    Get full text
    Journal Article
  15. 15

    Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences by Olivennes, F, Diedrich, K, Frydman, R, Felberbaum, RE, Howles, CM

    Published in Reproductive biomedicine online (2003)
    “…Gonadotrophin-releasing hormone antagonists are effective and safe in preventing premature LH surges, a leading cause of cycle cancellation or failure during…”
    Get full text
    Journal Article
  16. 16

    Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rational, results, reflections refinements by Homburg, R, Howles, CM

    Published in Human reproduction update (01-09-1999)
    “…Low-dose follicle stimulating hormone (FSH) regimens for induction of ovulation for women with polycystic ovaries have succeeded in reducing the rate of…”
    Get full text
    Journal Article
  17. 17

    A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women by Hedon, B, Hugues, J N, Emperaire, J C, Chabaud, J J, Barbereau, D, Boujenah, A, Howles, C M, Truong, F

    Published in Human reproduction (Oxford) (01-10-1998)
    “…The efficacy and safety of a chronic low dose (group A) and a conventional (group B) stimulation regimen of recombinant human follicle stimulating hormone…”
    Get full text
    Journal Article
  18. 18

    Effect of luteinizing hormone on follicle stimulating hormone-activated paracrine signalling in rat ovary by Smyth, C D, Miró, F, Howles, C M, Hillier, S G

    Published in Human reproduction (Oxford) (01-01-1995)
    “…'Pure' follicle stimulating hormone (FSH) and luteinizing hormone (LH) are expected shortly to become available for pharmaceutical use in the clinical setting…”
    Get more information
    Journal Article
  19. 19

    Endocrine monitoring for assisted human conception by Howles, C M, Macnamee, M C

    Published in British medical bulletin (01-07-1990)
    “…The pregnancy potential of an assisted conception treatment cycle increases with the number of oocytes or embryos returned to the patient. It is therefore…”
    Get more information
    Journal Article
  20. 20

    Pregnancies after IVF when high tonic LH is reduced by long-term treatment with GnRH agonists by Macnamee, M C, Howles, C M, Edwards, R G

    Published in Human reproduction (Oxford) (01-10-1987)
    “…Some patients show high output of urinary LH when superovulated with clomiphene citrate and HMG. Recent evidence has shown that this is detrimental to…”
    Get more information
    Journal Article